Chris Greene

2.8k total citations · 2 hit papers
21 papers, 1.6k citations indexed

About

Chris Greene is a scholar working on Neurology, Molecular Biology and Neurology. According to data from OpenAlex, Chris Greene has authored 21 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Neurology, 6 papers in Molecular Biology and 4 papers in Neurology. Recurrent topics in Chris Greene's work include Barrier Structure and Function Studies (14 papers), Neurological Disease Mechanisms and Treatments (5 papers) and Advanced Neuroimaging Techniques and Applications (4 papers). Chris Greene is often cited by papers focused on Barrier Structure and Function Studies (14 papers), Neurological Disease Mechanisms and Treatments (5 papers) and Advanced Neuroimaging Techniques and Applications (4 papers). Chris Greene collaborates with scholars based in Ireland, United States and United Kingdom. Chris Greene's co-authors include Matthew Campbell, Nicole Hanley, John Kealy, Eoin O’Keeffe, Colin P. Doherty, Arnold Münnich, Ruairi Connolly, Yosuke Hashimoto, Emma Connolly and James F. Meaney and has published in prestigious journals such as Nature Communications, Nano Letters and Nature Neuroscience.

In The Last Decade

Chris Greene

20 papers receiving 1.6k citations

Hit Papers

Claudin-5: gatekeeper of neurological function 2019 2026 2021 2023 2019 2024 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chris Greene Ireland 14 710 522 240 223 176 21 1.6k
Aric F. Logsdon United States 20 529 0.7× 535 1.0× 572 2.4× 363 1.6× 136 0.8× 33 1.8k
Antonio Boza‐Serrano Sweden 18 830 1.2× 767 1.5× 327 1.4× 471 2.1× 162 0.9× 28 2.1k
Pengfei Xu China 22 1.1k 1.6× 889 1.7× 253 1.1× 271 1.2× 179 1.0× 43 2.4k
Andrew D. Greenhalgh Canada 22 1.3k 1.8× 676 1.3× 310 1.3× 270 1.2× 176 1.0× 34 2.7k
Reiko Kuno Japan 12 692 1.0× 473 0.9× 157 0.7× 275 1.2× 118 0.7× 16 1.5k
Filipa L. Cardoso Portugal 12 498 0.7× 380 0.7× 98 0.4× 125 0.6× 69 0.4× 13 1.1k
Cataldo Arcuri Italy 24 553 0.8× 1.4k 2.8× 343 1.4× 419 1.9× 97 0.6× 53 2.5k
Ke Liao United States 30 793 1.1× 1.2k 2.3× 247 1.0× 171 0.8× 195 1.1× 73 2.5k
Benjamin Pulli United States 20 320 0.5× 430 0.8× 280 1.2× 408 1.8× 84 0.5× 53 2.0k

Countries citing papers authored by Chris Greene

Since Specialization
Citations

This map shows the geographic impact of Chris Greene's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Greene with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Greene more than expected).

Fields of papers citing papers by Chris Greene

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Greene. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Greene. The network helps show where Chris Greene may publish in the future.

Co-authorship network of co-authors of Chris Greene

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Greene. A scholar is included among the top collaborators of Chris Greene based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Greene. Chris Greene is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Greene, Chris, Nicole Hanley, Charitini Salla, et al.. (2025). Restoration of blood brain barrier integrity post neurosurgical resection in drug resistant epilepsy. Epilepsy & Behavior. 168. 110425–110425. 2 indexed citations
3.
Greene, Chris, Ruairi Connolly, Aoife Laffan, et al.. (2024). Blood–brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nature Neuroscience. 27(3). 421–432. 178 indexed citations breakdown →
4.
Hashimoto, Yosuke, Chris Greene, Nicole Hanley, et al.. (2024). Pumilio-1 mediated translational control of claudin-5 at the blood-brain barrier. Fluids and Barriers of the CNS. 21(1). 52–52. 2 indexed citations
5.
Greene, Chris, et al.. (2024). NX210c drug candidate peptide strengthens mouse and human blood-brain barriers. Fluids and Barriers of the CNS. 21(1). 76–76. 3 indexed citations
6.
Hashimoto, Yosuke, Chris Greene, Arnold Münnich, & Matthew Campbell. (2023). The CLDN5 gene at the blood-brain barrier in health and disease. Fluids and Barriers of the CNS. 20(1). 22–22. 63 indexed citations
7.
Greene, Chris, Nicole Hanley, Cristina R. Reschke, et al.. (2022). Microvascular stabilization via blood-brain barrier regulation prevents seizure activity. Nature Communications. 13(1). 2003–2003. 101 indexed citations
8.
Greene, Chris, Karen Frudd, Clare E. Futter, et al.. (2022). Methamphetamine enhances caveolar transport of therapeutic agents across the rodent blood-brain barrier. Cell Reports Medicine. 3(1). 100497–100497. 9 indexed citations
9.
Ozaki, Ema, Chris Greene, Michael Carty, et al.. (2022). SARM1 Promotes Photoreceptor Degeneration in an Oxidative Stress Model of Retinal Degeneration. Frontiers in Neuroscience. 16. 852114–852114. 5 indexed citations
10.
Greene, Chris & Matthew Campbell. (2022). Immunohistochemical Analysis of Tight Junction Proteins. Methods in molecular biology. 2492. 307–314. 1 indexed citations
11.
Li, Xiaoqing, Vamsidhara Vemireddy, Qi Cai, et al.. (2021). Reversibly Modulating the Blood–Brain Barrier by Laser Stimulation of Molecular-Targeted Nanoparticles. Nano Letters. 21(22). 9805–9815. 81 indexed citations
12.
Reschke, Cristina R., Luiz Fernando Almeida Silva, Vamshidhar R. Vangoor, et al.. (2021). Systemic delivery of antagomirs during blood-brain barrier disruption is disease-modifying in experimental epilepsy. Molecular Therapy. 29(6). 2041–2052. 25 indexed citations
13.
Delaney, Conor P., Michael Farrell, Colin P. Doherty, et al.. (2020). Attenuated CSF‐1R signalling drives cerebrovascular pathology. EMBO Molecular Medicine. 13(2). e12889–e12889. 35 indexed citations
14.
Mulfaul, Kelly, Ema Ozaki, Nilisha Fernando, et al.. (2020). Toll-like Receptor 2 Facilitates Oxidative Damage-Induced Retinal Degeneration. Cell Reports. 30(7). 2209–2224.e5. 45 indexed citations
15.
Greene, Chris, Nicole Hanley, & Matthew Campbell. (2020). Blood-brain barrier associated tight junction disruption is a hallmark feature of major psychiatric disorders. Translational Psychiatry. 10(1). 373–373. 139 indexed citations
16.
Hudson, Natalie, A. Hopkins, Chris Greene, et al.. (2019). Dysregulated claudin-5 cycling in the inner retina causes retinal pigment epithelial cell atrophy. JCI Insight. 4(15). 50 indexed citations
17.
Greene, Chris, Nicole Hanley, & Matthew Campbell. (2019). Claudin-5: gatekeeper of neurological function. Fluids and Barriers of the CNS. 16(1). 3–3. 389 indexed citations breakdown →
18.
Kealy, John, Chris Greene, & Matthew Campbell. (2018). Blood-brain barrier regulation in psychiatric disorders. Neuroscience Letters. 726. 133664–133664. 213 indexed citations
19.
Greene, Chris & Matthew Campbell. (2016). Tight junction modulation of the blood brain barrier: CNS delivery of small molecules. Tissue Barriers. 4(1). e1138017–e1138017. 178 indexed citations
20.
Greene, Chris, Ciarán J. Mooney, Laura Collins, et al.. (2014). Embryonic rat vascular smooth muscle cells revisited - a model for neonatal, neointimal SMC or differentiated vascular stem cells?. PubMed. 6(1). 6–6. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026